SUPN
Supernus Pharmaceuticals Inc
42.40$
+0.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 6.0% | 6.0% | 5.1% | 5.1% | 5.3% | 4.7% | 3.6% | 3.7% | 4.1% | 3.6% | 4.3% | 3.9% | 4.7% | 4.1% | 4.4% | 6.6% | 13.8% | 12.9% | 11.4% | 17.7% | 12.2% | 10.7% | 11.8% | 12.0% | 14.6% | 13.7% | 15.3% | 15.6% | 12.7% | 11.9% | 11.4% | 10.6% | 10.0% | 15.0% | 10.5% | 10.2% | 9.9% | 10.9% | 11.3% | 15.4% | 11.9% | |
| 94.0% | 94.0% | 94.9% | 94.9% | 94.7% | 95.3% | 96.4% | 96.3% | 95.9% | 96.4% | 95.7% | 96.1% | 95.3% | 95.9% | 95.6% | 93.4% | 86.2% | 87.1% | 88.6% | 82.3% | 87.8% | 89.3% | 88.2% | 88.0% | 85.4% | 86.3% | 84.7% | 84.4% | 87.3% | 88.1% | 88.6% | 89.4% | 90.0% | 85.0% | 89.5% | 89.8% | 90.1% | 89.1% | 88.7% | 84.6% | 88.1% | |
| 13.8% | 21.2% | 16.7% | 14.3% | 16.1% | 18.3% | 20.9% | 20.1% | 19.8% | 25.7% | 18.0% | 16.2% | 16.6% | 19.7% | 19.9% | 17.6% | 10.9% | 12.5% | 26.2% | 10.9% | 13.2% | 13.3% | 13.7% | 9.6% | 11.0% | 10.6% | 13.8% | 18.0% | 14.7% | 14.2% | 17.4% | 15.6% | 16.5% | 16.4% | 18.0% | 13.4% | 15.3% | 13.2% | 19.0% | 13.4% | 15.2% | |
| 45.2% | 37.4% | 37.4% | 33.3% | 38.8% | 29.5% | 32.0% | 29.1% | 28.4% | 25.2% | 12.0% | 9.1% | 9.6% | 27.3% | 13.2% | 15.4% | 10.5% | 13.7% | 17.6% | 15.0% | 14.4% | 64.0% | 19.6% | 15.8% | 15.0% | 15.5% | 18.4% | 19.8% | 16.8% | 15.8% | 18.8% | 16.1% | 8.8% | 14.2% | 17.8% | 17.2% | 53.4% | 18.5% | 60.3% | 18.6% | 37.1% | |
| 59.0% | 67.8% | 65.7% | 60.5% | 66.9% | 56.5% | 61.7% | 60.4% | 59.5% | 62.0% | 65.9% | 55.4% | 56.4% | 55.3% | 65.1% | 57.4% | 50.0% | 57.1% | 78.5% | 58.2% | 65.9% | 95.5% | 87.0% | 81.3% | 86.3% | 65.8% | 81.4% | 97.4% | 82.0% | 88.7% | 90.8% | 75.9% | 66.7% | 72.7% | 96.3% | 82.5% | 121.5% | 82.6% | 92.7% | 111.1% | 101.6% | |
| 34.9% | 26.1% | 29.2% | 34.4% | 27.8% | 38.8% | 34.7% | 35.9% | 36.4% | 34.4% | 29.7% | 40.7% | 38.9% | 40.6% | 30.5% | 35.9% | 36.2% | 30.0% | 10.1% | 24.1% | 22.0% | 4.5% | 1.3% | 6.7% | -0.9% | 20.5% | 3.4% | -13.0% | 5.3% | -0.6% | -2.2% | 13.4% | 23.2% | 12.3% | -6.8% | 7.3% | -31.4% | 6.5% | -3.6% | -26.5% | -13.5% | |
| 2.1% | 1.5% | 1.8% | 0.3% | 0.2% | 0.2% | 1.6% | 5.6% | 5.4% | 4.8% | 6.9% | 5.1% | 5.5% | 5.8% | 6.1% | 4.6% | 3.9% | 4.2% | 4.7% | 3.9% | 4.0% | 3.7% | 1.3% | 1.1% | 1.0% | 1.0% | 1.0% | 0.7% | 0.0% | 2.9% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | – | – | – | 1.1% | – | |
| 33.7% | 24.9% | 28.2% | 34.8% | 28.5% | 39.6% | 34.5% | 34.0% | 35.3% | 33.4% | 28.4% | 40.8% | 38.8% | 40.7% | 30.6% | 37.3% | 34.0% | 27.6% | 8.3% | 22.1% | 19.5% | 1.3% | 9.7% | 6.7% | -0.3% | 21.0% | 5.9% | -12.6% | 6.4% | 0.6% | 0.2% | 15.6% | 25.6% | 15.1% | -3.9% | 10.1% | -30.2% | -0.9% | -2.9% | -26.3% | -14.9% | |
| -75.1% | 2.0% | 10.3% | 11.9% | 8.6% | 24.2% | 5.3% | 3.1% | 8.1% | 11.1% | 6.9% | 9.6% | 10.5% | 7.7% | 7.9% | 9.9% | 8.2% | 6.2% | 4.0% | 5.3% | 5.0% | -0.2% | -7.1% | 2.0% | -1.2% | 5.8% | -5.2% | -12.0% | 16.8% | -0.1% | 0.1% | 3.8% | 3.7% | 6.3% | 4.0% | -3.5% | -6.7% | 1.0% | -1.8% | 0.3% | -1.6% | |
| 108.8% | 23.0% | 17.9% | 22.9% | 19.9% | 15.4% | 29.1% | 30.9% | 27.2% | 22.3% | 21.5% | 31.3% | 28.3% | 33.0% | 22.7% | 27.4% | 25.8% | 21.4% | 4.3% | 16.8% | 14.5% | 1.5% | 16.8% | 4.6% | 1.0% | 15.2% | 11.0% | -0.6% | -10.4% | 0.7% | 0.1% | 11.8% | 21.9% | 8.8% | -7.9% | 13.6% | -23.5% | -1.9% | -1.1% | -26.6% | -13.2% | |
| 36.0% | 27.2% | 30.4% | 36.1% | 33.2% | 40.7% | 36.6% | 37.7% | 38.2% | 47.9% | 37.2% | 47.5% | 40.5% | 48.2% | 38.5% | 44.2% | 43.0% | 35.7% | 18.0% | 30.7% | 28.0% | 13.0% | 24.9% | 20.4% | 13.0% | 34.4% | 20.2% | 3.3% | 20.6% | 13.8% | 11.5% | 23.1% | 37.0% | 26.0% | 11.9% | 23.0% | -17.3% | 12.6% | 9.7% | -13.5% | -1.9% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.